Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) Non Operating Income (2024 - 2025)

Caris Life Sciences has reported Non Operating Income over the past 2 years, most recently at -$94.8 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$94.8 million for Q4 2025, down 486.47% from a year ago — trailing twelve months through Dec 2025 was -$132.4 million (changed N/A YoY), and the annual figure for FY2025 was -$113.2 million, down 32335.82%.
  • Non Operating Income for Q4 2025 was -$94.8 million at Caris Life Sciences, down from -$8.3 million in the prior quarter.
  • Over the last five years, Non Operating Income for CAI hit a ceiling of $24.5 million in Q4 2024 and a floor of -$94.8 million in Q4 2025.